(Q38397934)

English

Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers

scientific article published on January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Vilmundur Gudnason

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Laufey Tryggvadottir

18

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

20

object named as

Göran Wadell

0 references

Tapio Luostarinen

object named as

Tapio Luostarinen

13

0 references

1

object named as

Eero Pukkala

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Göran Hallmans

6

object named as

Göran Hallmans

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

23

object named as

Joakim Dillner

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

12

object named as

Per Lenner

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

19

object named as

Jarmo Virtamo

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

16

object named as

Pär Stattin

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Pekka Jousilahti

8

object named as

Pekka Jousilahti

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

author name string

Aage Andersen

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Göran Berglund

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Randi Gislefoss

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Egil Jellum

7

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Paul Knekt

9

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Pentti Koskela

10

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

P Pentti Kyyrönen

11

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Arthur Löve

14

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Helga Ogmundsdóttir

15

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Leena Tenkanen

17

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Anders Widell

21

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Matti Lehtinen

22

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Acta Oncologica

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

286-307

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Serum p53 accumulation and altered antibody responses to Epstein-Barr virus proteins precede diagnosis of haemopoietic malignancies of lymphoid origin.

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Stability over time of serum antibody levels to human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11.

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Chlamydia trachomatis infection as a risk factor for invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Associations between three types of maternal bacterial infection and risk of leukemia in the offspring

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Chlamydial antibodies and risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries).

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Pre- and posttreatment serum antibody responses to HPV 16 E2 and HSV 2 ICP8 proteins in women with cervical carcinoma

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14,000 cases and 32,000 controls in the United Kingdom. The International Studies of Infarct Survival (ISIS) Collaborators

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Underestimation of Risk Associations Due to Regression Dilution in Long-term Follow-up of Prospective Studies

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Experiences of the Janus Serum Bank in Norway

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Data quality and quality control of a population-based cancer registry. Experience in Finland

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Design options for molecular epidemiology research within cohort studies

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Selection of controls in case-control studies. III. Design options

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later

1 reference

https://api.crossref.org/works/10.1080%2F02841860701203545

21 January 2018

Identifiers

10.1080/02841860701203545

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38397934&oldid=2073990683"